🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
Main objective is to investigate mutual pharmacokinetic drug-drug interacti...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2016-08-22
Trial ID
NCT02854527
Treatments Being Tested
The objective of the present study is to contribute to establishing in vivo...
Status
Completed
Location
Department of Pharmacology I, University Hospital Cologne
Start Date
2016-04
Trial ID
NCT02743260
Treatments Being Tested
The primary objective of this trial is to investigate the relative bioavail...
Status
Completed
Location
CTC North GmbH & Co. KG, Hamburg
Start Date
2017-10-25
Trial ID
NCT03307252
Treatments Being Tested
The purpose of this study is to evaluate the effects of repeat dosing of JN...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-02-12
Trial ID
NCT02592317
Treatments Being Tested
This is a Phase 1, open-label, fixed-sequence, 2-part DDI study. Subjects w...
Status
Completed
Location
Site 1
Start Date
2023-01-03
Trial ID
NCT05657613
This Study evaluates the Effect of St. John's Wort dry Extract Ze 117 on Se...
Status
Completed
Location
Nuvisan GmbH
Start Date
2018-02-05
Trial ID
NCT03482817
Treatments Being Tested
New/direct oral anticoagulants (NOAC/DOAC), like apixaban and rivaroxaban, ...
Status
Completed
Location
HUG
Start Date
2017-06-28
Trial ID
NCT03112525
Treatments Being Tested
This study consisted of 2 parts: Part 1 and 2. The purpose of this study wa...
Status
Completed
Location
Nuvisan GmbH
Start Date
2021-10-04
Trial ID
NCT05064488
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy and pharmacok...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-07-31
Trial ID
NCT05967689
Treatments Being Tested